iLABMED

Guanghui Ma

Institute of Process Engineering, CAS, Beijing, China

Guanghui Ma is a professor of the State Key Laboratory of Biochemical Engineering (SKLBCE), Institute of Process Engineering (IPE). She is an academician of CAS in China and AIMBE fellow. Her research interests focus on the preparation of uniform microspheres and microcapsules and their applications in biochemical engineering and biomedicine engineering, such as biochemical separation media, drug carriers, vaccine adjuvants (vaccine delivery systems), microcarriers for cell culture, and enzyme immobilization carriers. She has published over 400 papers which has been cited for over 12,000 times, including Nat. Mater., Nat. Biomed. Eng., Nat. Commun., Sci. Adv., JACS, Adv. Mater., etc.

Hongzhou Lu

Third People's Hospital of Shenzhen, Shenzhen, China

Hongzhou Lu is the Hospital Chief Executive of Third People's Hospital of Shenzhen. His research interests include Tuberculosis, Hepatitis, AIDS, Zoonosis. Prof. Lu has published 480 peer-reviewed articles in the past 20 years including more than 300 in journals such as Nature and New England Journal of Medicine. He has selected by Stanford University's World's Top 2% Scientists 2021 and Lifetime Science Influence rankings and elected as a fellow of the American Academy of Microbiology in February 2022.

Tetsuya Asakawa

Third People's Hospital of Shenzhen, Shenzhen, China

Dr. Tetsuya Asakawa is a full professor/chairman of the Institute of Neurology, The Third People's Hospital of Shenzhen. His research focuses on the clinical neurology, general neuroscience, molecular imaging and traditional Chinese medicine. He is a leading scientist in the fields of behavioral assessment in Parkinson's disease (PD), neuroprotective effects of neuroserpin, and evidence-based medicine in traditional Chinese medicine. Dr. Asakawa has published 68 peer-reviewed articles as the first/corresponding author including the top journals like the Lancet, Neurosci Biobehav Rev, molecular Oncology, and Current neuropharmacology. He has published two books in Springer, and has served as a principal investigator of five grants from the Japan Society for the Promotion of Science. In 2021, he left for China and became a full professor working in Shenzhen. Now, other than his research, he is also engaging in the translational medicine and rehabilitation in China.

Yi-Wei Tang

Danaher/Cepheid, New York, USA

Yi-Wei Tang is the Chief Medical Officer of Danaher Diagnostic Platform/Cepheid China. His research interests include clinical and molecular microbiology. Prof. Tang has published over 300 peer-reviewed articles in scientific journals in the past 30 years. He is currently an Editor for the Journal of Clinical Microbiology, an Associate Editor for the Journal of Molecular Diagnostics, an Associate Editor for the Emerging Microbes and Infection, a Fellow of the American Academy for Microbiology and of the Infectious Disease Society of America.

Jie Liu

he Seventh Medical Center of Chinese PLA General Hospital, Beijing, China

Jie Liu is the director of Department of Laboratory,The Seventh Medical Center of Chinese PLA General Hospital. His research interests include Clinical Laboratory Diagnostics and AI. Prof. Liu has published 10 peer-reviewed articles in Annals of Translational Medicine etc in the past 5 years. He has made other major achievements/contributions

• THE UNITED NATIONS MEDAL
• The Fourth National Bethune Good Doctor
• Executive Editor of Modern Medicine and Health Research
• Executive Editor in Chief of Big Doctor
• 33 monographs published
• Vice President of POCT Equipment Technology Branch of China Medical Equipment Association
• Vice President of Laboratory Medicine Branch of Bethune Institute of Psychiatry

Xuhu Mao

Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory Science, Army Medical University, Chongqing, China

Mao Xu-hu is the director of department of clinical microbiology and immunology, college of pharmacy and medical laboratory science, army medical university. His research interests include infection and immunity of pathogens, especially pathogenesis mechanisms, development of vaccines, and diagnosis. In the past 10 years, Prof. Mao has published over 20 peer-reviewed articles in Lancet, Cell reports, Autophagy, et al. Now he also lead the innovation team of vaccine development for bacteria, ministry of science and technology, China.

Tohru Takata

Department of Infection Control, Fukuoka University Hospital Department of Oncology, Hematology, and Infectious Diseases, Fukuoka University School of Medicine, Fukuoka, Japan

Tohru Takata, MD, PhD.,a Professor of Department of Infection Control, Fukuoka University Hospital. His research interests include clinical infectious diseases, clinical microbiology, and infection control of opportunistic infections in immunocomprimosed patients . Prof. Takata has published 63 peer-reviewed articles in Nature,Nature Communication,Diagnostic Microbiology and Infectious Disease et.al.

Wun-Ju Shieh

Infectious Diseases Pathology Branch, Centers for Disease Control and Prevention (Retired), Atlanta, USA

Dr. Wun-Ju Shieh was the former Deputy Branch Chief at the Infectious Diseases Pathology Branch, Centers for Disease Control and Prevention (CDC) and retired in July 2020 after 25 years of service. He recently joined the 2022-2024 roster of American Society for Microbiology Distinguished Lecturer (ASMDL) program. He participated many outbreak investigations during his tenure at CDC. He has authored or co-authored more than 200 scientific articles and 12 book chapters, including 28 in the past five years. He has delivered more than 250 talks at international, national, regional meetings, workshops, and various institutes in the past thirty years.

Jian Xu

Director, Single-Cell Center; Qingdao Institute of BioEnergy and Bioprocess Technology (QIBEBT), Chinese Academy of Sciences, Qingdao, China

Jian obtained B.S in Biotechnology from Peking University in 1997, and M.S. in Computer Science and PhD in Biochemistry under Jeffrey Gordon from Washington University in St. Louis in 2003. After serving as Research Instructor at Genome Institute of Washington University, he joined Qingdao Institute of BioEnergy and Bioprocess Technology, Chinese Academy of Sciences (CAS-QIBEBT) in 2008 and has been the founding Director of Single-Cell Center, CAS-QIBEBT. Jian has published over 140 papers on leading journals such as Science, Cell Host & Microbe, etc, with ~15,000 citations (H-index 57). Jian's research lies in instrument development for single-cell Raman imaging, sorting and sequencing (RACS-Seq, CAST-R, FlowRACS, EasySort, etc), microbiome and diseases, and microbiome big-data and artificial intelligence. His contribution was recognized by a number of career awards from NSFC, MOST and CAS, including National Distinguished Young Scholars Award (2014), National Young-Scientist Award for Science and Technology (2016) and VCANBIO Award for Biosciences and Medicine (2016).